Stock Events

Stock Events

Astrazeneca 

$156.69
6324
+$0.24+0.15% 12:53 Today

Statistics

Day High
156.46
Day Low
154.54
52W High
212.71
52W Low
145.8
Volume
3,482,397
Avg. Volume
2,820,948
Mkt Cap
242.64B
P/E Ratio
26.9
Dividend Yield
2.06%
Dividend
3.22

Upcoming

Dividends

2.06%Dividend Yield
Sep 26
$1.08
Mar 26
$2.14
Sep 25
$2.08
Mar 25
$4.34
Sep 24
$2.03
10Y Growth
-3.81%
5Y Growth
-5.41%
3Y Growth
-10%
1Y Growth
-33.74%

Earnings

30OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
2.09
2.27
2.45
2.63
Expected EPS
2.626509
Actual EPS
N/A

Financials

17.41%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
58.74BRevenue
10.23BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AZN. It's not an investment recommendation.
Legal & General Group
1159
LGEN.LSE
BP
1101
BP.LSE
Aviva
961
AV.LSE
National Grid
958
NG.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a direct competitor in various therapeutic areas including oncology, vaccines, and cardiovascular health, similar to AstraZeneca's portfolio.
Merck
MRK
Mkt Cap335.14B
Merck & Co. competes closely with AstraZeneca, especially in the oncology sector with its leading cancer treatments.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in areas like immunology and oncology.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline competes with AstraZeneca in respiratory diseases, oncology, and vaccine development.
Novartis
NVS
Mkt Cap286.78B
Novartis competes across several of the same therapeutic areas as AstraZeneca, including cardiovascular, oncology, and respiratory.
Roche
RHHBY
Mkt Cap334.28B
Roche, with its strong portfolio in oncology and diagnostics, is a major competitor, especially in cancer treatment.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb competes in the oncology space, particularly with its range of cancer therapies.
Sanofi
SNY
Mkt Cap104.76B
Sanofi competes with AstraZeneca in areas such as diabetes, cardiovascular diseases, and vaccines.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie, with its biopharmaceutical focus, competes in immunology and oncology, similar to AstraZeneca's research areas.
AMGEN
AMGN
Mkt Cap224.63B
Amgen's focus on biologic medicines in areas like oncology and cardiovascular disease places it as a competitor to AstraZeneca.

About

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Show more...
CEO
Pascal Claude Roland Soriot
Employees
96100
Country
United Kingdom
ISIN
GB0009895292
WKN
000886715

Listings

MX
MX
AZN1N.MX
STU
DE
ZEG.STU
XNYS
US
AZN
LSE
GB
AZN.LSE

0 Comments

Share your thoughts

FAQ

What is Astrazeneca stock price today?▼
The current price of AZN is $156.69 USD — it has increased by +0.15% in the past 24 hours. Watch Astrazeneca stock price performance more closely on the chart.
What is Astrazeneca stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Astrazeneca stocks are traded under the ticker AZN.
Is Astrazeneca stock price growing?▼
AZN stock has fallen by -3.37% compared to the previous week, the month change is a -7.37% fall, over the last year Astrazeneca has showed a -1.19% decrease.
What is Astrazeneca market cap?▼
Today Astrazeneca has the market capitalization of 242.64B
When is the next Astrazeneca earnings date?▼
Astrazeneca is going to release the next earnings report on October 30, 2026.
What were Astrazeneca earnings last quarter?▼
AZN earnings for the last quarter are 2.63 USD per share, whereas the estimation was 2.48 USD resulting in a +6.21% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Astrazeneca revenue for the last year?▼
Astrazeneca revenue for the last year amounts to 58.74B USD.
What is Astrazeneca net income for the last year?▼
AZN net income for the last year is 10.23B USD.
Does Astrazeneca pay dividends?▼
Yes, AZN dividends are paid semi-annual. The last dividend per share was 2.14 USD. As of today, Dividend Yield (FWD)% is 2.06%.
How many employees does Astrazeneca have?▼
As of August 17, 2026, the company has 96,100 employees.
In which sector is Astrazeneca located?▼
Astrazeneca operates in the Health & Wellness sector.
When did Astrazeneca complete a stock split?▼
The last stock split for Astrazeneca was on February 02, 2026 with a ratio of 1:2.
Where is Astrazeneca headquartered?▼
Astrazeneca is headquartered in Cambridge, United Kingdom.